Another study by Wu et al. demonstrated that MAP4K1 downregulation can inhibit the progression of gastric cancer by suppressing cell proliferation, migration and epithelial–mesenchymal transition (EMT)26. This evidence concerns the gene MAP4K1 and gastric cancer.